MicroPort Endovascular MedTech announces share repurchase progress

Shanghai MicroPort Endovascular MedTech (SSE:688016) has announced the progress of its second phase of share repurchase, executed through centralized bidding transactions. As of June 30, 2025, the company has repurchased 953,841 shares, representing 0.77% of the total share capital. The repurchase was conducted at prices ranging from CNY 84.26 to CNY 119.82 per share, totaling CNY 99,407,696.44 (excluding stamp duty, transaction commissions, and other transaction expenses). The company's repurchase plan, initiated on October 28, 2024, aims to repurchase shares for equity incentives or employee stock ownership plans, with a total repurchase amount between CNY 100 million and CNY 200 million at a price not exceeding CNY 178.01 per share. The company will continue to implement the repurchase plan based on market conditions and fulfill its information disclosure obligations.